Evidence map›Paper›PMID 39138263›Full record

ArticleOncogene2024

Hypoxia-induced LAMB2-enriched extracellular vesicles promote peritoneal metastasis in gastric cancer via the ROCK1-CAV1-Rab11 axis.

Dongyang Li, Yue Jin, Xin He, Jian Deng, Wenqing Lu, Zichang Yang, Xueying Zheng, Kezuo Hou, Shiying Tang, Bowen Bao and 7 more

Abstract read
PubMed Publisher
In one paragraph

Article in Oncogene, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Extracellular vesicles in laboratory medicine: a review and outlook.Frontiers in cell and developmental biology · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Dongyang LiDepartment of Medical Oncology, The First Hospital of China Medical University, Shenyang, China.ORCID 0009-0001-5625-6588
Yue JinDepartment of Medical Oncology, The First Hospital of China Medical University, Shenyang, China.
Xin HeDepartment of Medical Oncology, The First Hospital of China Medical University, Shenyang, China.
Jian DengThird Department of Medical Oncology, The Fifth People Hospital of Shenyang, Shenyang, China.
Wenqing LuDepartment of Medical Oncology, The First Hospital of China Medical University, Shenyang, China.
Zichang YangDepartment of Medical Oncology, The First Hospital of China Medical University, Shenyang, China.
Xueying ZhengDepartment of Medical Oncology, The First Hospital of China Medical University, Shenyang, China.
Kezuo HouDepartment of Medical Oncology, The First Hospital of China Medical University, Shenyang, China.
Shiying TangDepartment of Medical Oncology, The First Hospital of China Medical University, Shenyang, China.
Bowen BaoDepartment of Medical Oncology, The First Hospital of China Medical University, Shenyang, China.
Jie RenDepartment of Medical Oncology, The First Hospital of China Medical University, Shenyang, China.
Xiaojie ZhangDepartment of Medical Oncology, The First Hospital of China Medical University, Shenyang, China.
Jin WangDepartment of Medical Oncology, The First Hospital of China Medical University, Shenyang, China.
Hongfei YanDepartment of Medical Oncology, The First Hospital of China Medical University, Shenyang, China.
Xiujuan QuDepartment of Medical Oncology, The First Hospital of China Medical University, Shenyang, China.
Yunpeng LiuDepartment of Medical Oncology, The First Hospital of China Medical University, Shenyang, China. ypliu@cmu.edu.cn.ORCID 0000-0002-9645-7990
Xiaofang CheDepartment of Medical Oncology, The First Hospital of China Medical University, Shenyang, China. xfche@cmu.edu.cn.ORCID 0000-0002-9087-1007

Funding

National Natural Science Foundation of China (National Science Foundation of China) 32170791National Natural Science Foundation of China (National Science Foundation of China) 81902998National Natural Science Foundation of China (National Science Foundation of China) 81972331National Natural Science Foundation of China (National Science Foundation of China) 81972751National Natural Science Foundation of China (National Science Foundation of China) 82102929National Natural Science Foundation of China (National Science Foundation of China) 82203841National Natural Science Foundation of China (National Science Foundation of China) 82272853
6 · The paper itself

Abstract

Peritoneal metastasis is one of the most common risk factors contributing to the poor prognosis of gastric cancer. We previously reported that extracellular vesicles from gastric cancer cells could facilitate peritoneal metastasis. However, their impact on gastric cancer-induced peritoneal metastasis under hypoxic conditions remains unclear. This study aims to elucidate how hypoxia-resistant gastric cancer cell-derived extracellular vesicles affect the peritoneal metastasis of normoxic gastric cancer cells. Proteomic analysis revealed elevated levels of Caveolin1 and Laminin β2 in hypoxia-resistant gastric cancer cells and their corresponding extracellular vesicles. Importantly, Caveolin1 was found to play a central role in mediating Laminin β2 sorting into extracellular vesicles derived from hypoxia-resistant gastric cancer cells, and subsequently, extracellular vesicle-associated Laminin β2 promoted peritoneal metastasis in normoxic gastric cancer cells by activating the AKT pathway. Further investigation confirmed that Caveolin1 activation by Rho-related Coiled-coil kinase 1-mediated phosphorylation of Y14 residue is a key factor facilitating Laminin β2 sorting into extracellular vesicles. Moreover, Y14 phosphorylated- Caveolin1 enhanced Laminin β2 sorting by activating Rab11. Finally, our study demonstrated that a combined assessment of plasma extracellular vesicle-associated Caveolin1 and extracellular vesicle-associated Laminin β2 could provide an accurate predictive tool for peritoneal metastasis occurrence in gastric cancer.

Indexed as

Caveolin 1Extracellular VesiclesPeritoneal Neoplasmsrab GTP-Binding Proteinsrho-Associated KinasesStomach NeoplasmsAnimalsCell Line, TumorFemaleHumansMaleMicerab11 GTP-Binding ProteinsSignal TransductionCAV1 protein, humanCaveolin 1rab11 GTP-Binding Proteinsrab GTP-Binding Proteinsrho-Associated KinasesROCK1 protein, human

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.